Business Context and Reporting Period
This Form 8-K filing by The Chemours Company (Chemours) was submitted on August 12, 2019. The report discloses specific appointments within the company's finance leadership team under Item 5.02.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointments.
Material Changes
The material change reported is the restructuring of senior finance roles:
- Matthew S. Abbott was appointed Vice President, Chief Accounting Officer and Controller, succeeding his previous role as Vice President and Chief Audit Executive.
- Amy P. Trojanowski was appointed Vice President, Business Finance and Shared Services, succeeding her previous role as Vice President, Chief Accounting Officer and Controller.
Guidance, Outlook, and Compensation Details
There is no forward-looking guidance, outlook, or discussion of risks and contingencies in this filing. The document details the compensatory arrangements for the new appointees:
- Matthew S. Abbott: Annual base salary of $325,000; target Annual Incentive Plan (AIP) award of 50% of base salary; target Long Term Incentive Plan (LTIP) award of $250,000.
- Amy P. Trojanowski: Specific compensation figures are not disclosed in this text.
Investor Verification Checklist
- Verify the effective date of the leadership transition for the Chief Accounting Officer role.
- Confirm the total compensation package for Amy P. Trojanowski in subsequent filings or proxy statements.
- Review the company's most recent 10-Q or 10-K for actual financial performance metrics, as this 8-K contains none.